Skip to content
StockMarketAgent
Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

ASX/BIT stock hub

ASX/BIT has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

ASX/BITis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
8.1M
Australian Securities Exchange
Market data

Live price

Current market quote for this ticker.

Current price
ASX/BIT
In the news

Latest news · ASX/BIT

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 12.9P50 20.4P75 41.2
Trailing P/En/a
P25 14.2P50 19.2P75 35.1
ROE-122.6
P25 -118.7P50 -49.4P75 -1.2
ROIC-77.9
P25 -74.7P50 -33.5P75 0.1
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All ASX/BIT market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
151
Groups with data
11
Currency
AUD
Showing 151 of 151 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
Australia
Country code
AU
Employees
3
Employees Change
-2%
Employees Change Percent
-40
Enterprise value
AUD 6.5M
Exchange
Australian Securities Exchange
Financial currency
AUD
First seen
2026-05-10
Industry
Biotechnology
Isin
AU000000BIT4
Last refreshed
2026-05-10
Market cap
AUD 8.1M
Price
AUD 0
Price currency
AUD
Rev Per Employee
-289.33x
Sector
Healthcare
Sic
2836
Symbol
asx/BIT
Website
https://www.biotron.com.au

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

4
MetricValue
Earnings Yield
-23.89%
EV Earnings
-3.34x
P/B ratio
3x
P/S ratio
-9,338.25x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

11
MetricValue
Gross Profit
AUD -868
Net Income
AUD -1.9M
Net Income Growth Years
2%
Pretax Margin
223,061.06%
Profit Per Employee
AUD -645,390
ROA
-50.99
Roa5y
-57.35
ROCE
-72.88
ROE
-122.6
Roe5y
-155.3
ROIC
-77.85

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

8
MetricValue
Cagr10y
-24.16%
Cagr15y
-18.63%
Cagr20y
-18.25%
Cagr3y
-51.46%
Cagr5y
-42.02%
EPS Growth Years
2
Revenue Growth
10.24x
Revenue Growth Years
2x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

15
MetricValue
Assets
AUD 3.9M
Cash
AUD 1.6M
Current Assets
AUD 1.7M
Current Liabilities
AUD 1.2M
Equity
AUD 2.7M
Liabilities
AUD 1.2M
Long Term Assets
AUD 2.2M
Long Term Liabilities
AUD 0
Net Cash
AUD 1.6M
Net Cash By Market Cap
AUD 20.27
Net Cash Growth
86.92%
Net Debt Equity
AUD -0.61
Tangible Book Value
AUD 569,165
Tangible Book Value Per Share
AUD 0
WACC
1.2

Liquidity

Current-asset coverage and working-capital efficiency metrics.

5
MetricValue
Current ratio
1.47
Net Working Capital
AUD -1.1M
Quick ratio
1.41
Working Capital
AUD 544,562
Working Capital Turnover
AUD -0

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
-43.86%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

35
MetricValue
10Y total return
-93.71%
200-day SMA
0
3Y total return
-88.57%
50-day SMA
0
50-day SMA vs 200-day SMA
50under200
5Y total return
-93.44%
All Time High
0.46
All Time High Change
-99.35%
All Time High Date
2003-07-28
All Time Low
0
All Time Low Change
50%
All Time Low Date
2025-04-11
ATR
0
Beta
-0.55
Beta1y
0.95
Beta2y
0.6
High
0
High52
0.01
High52 Date
2025-11-14
High52ch
-40%
Low
0
Low52
0
Low52 Date
2026-05-06
Low52ch
50%
Ma50ch
3.45%
Price vs 200-day SMA
0%
RSI
53.14
RSI Monthly
34.06
RSI Weekly
45.38
Sharpe ratio
0.97x
Sortino ratio
1.65
Total Return
-43.86%
Tr15y
-95.46%
Tr1m
50%
Tr3m
-14.29%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

2
MetricValue
Operating Income
AUD -2M
Operating margin
226,598.2

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

6
MetricValue
Float
1,955,150,751%
Shares Insiders
22.91%
Shares Institutions
0.43%
Shares Out
2,701,865,924
Shares Qo Q
36.84%
Shares Yo Y
43.86%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

44
MetricValue
Average Volume
663,526.9x
Bv Per Share
0
Ch10y
-95.38
Ch15y
-96.88
Ch1m
50
Ch20y
-98.78
Ch3m
-14.29
Ch3y
-90
Ch5y
-94.44
Ch6m
-25
Change
0%
Change From Open
0
Close
0
Days Gap
0
Depreciation Amortization
-1,712
Dollar Volume
1,208.4
Earnings Date
2026-05-27
EBIT
AUD -2M
EBITDA
AUD -2M
EPS
AUD -0
F Score
1
Financing CF
2,576,093
Fiscal Year End
June
Founded
1,999
Investing CF
111,513
Is Primary Listing
1
Last Earnings Date
2026-02-23
Last Report Date
2025-12-31
Ma150
0
Ma150ch
-6.25%
Ma20
0
Ma20ch
7.14%
Net CF
763,918
Next Earnings Date
2026-05-27
Open
0
Ppne
3,808
Price Date
2026-05-08
Ptbv Ratio
14.24
Relative Volume
0.61x
Revenue
-868x
Tr20y
-98.22%
Tr6m
-25%
Volume
402,784
Z Score
-20.26
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does ASX/BIT pay a dividend?

Capital-return profile for this ticker.

Performance

ASX/BIT stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
n/a
S&P 500 1Y: n/a
3Y total return
-88.6%
S&P 500 3Y: n/a
5Y total return
-93.4%
S&P 500 5Y: n/a
10Y total return
-93.7%
S&P 500 10Y: n/a
Ownership

Who owns ASX/BIT?

Insider, institutional, and short-interest positioning.

Institutional ownership
+0.4%
Share of float held by funds and institutions
Insider ownership
+22.9%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+43.9%
Negative means the company is buying back shares.
Technical

ASX/BIT momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
53.1
Neutral momentum band
Price vs 200-day MA
0.0%
50/200-day relationship not available
Beta (5Y)
-0.55
Less volatile than the market
Sharpe ratio
0.97
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About ASX/BIT

Hub-level FAQ points readers to the deeper analysis pages.

What is the current asx/BIT stock rating?

asx/BIT is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full asx/BIT analysis?

The full report lives at /stocks/asx/BIT/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for asx/BIT?

The latest report frames asx/BIT around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the asx/BIT page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.